224 related articles for article (PubMed ID: 28542329)
1. Novel AgoshRNA molecules for silencing of the CCR5 co-receptor for HIV-1 infection.
Herrera-Carrillo E; Berkhout B
PLoS One; 2017; 12(5):e0177935. PubMed ID: 28542329
[TBL] [Abstract][Full Text] [Related]
2. Silencing of HIV-1 by AgoshRNA molecules.
Herrera-Carrillo E; Harwig A; Berkhout B
Gene Ther; 2017 Aug; 24(8):453-461. PubMed ID: 28553929
[TBL] [Abstract][Full Text] [Related]
3. Design and Evaluation of AgoshRNAs with 3'-Terminal HDV Ribozymes to Enhance the Silencing Activity.
Berkhout B; Herrera-Carrillo E
Methods Mol Biol; 2021; 2167():225-252. PubMed ID: 32712923
[TBL] [Abstract][Full Text] [Related]
4. Towards Antiviral shRNAs Based on the AgoshRNA Design.
Liu YP; Karg M; Herrera-Carrillo E; Berkhout B
PLoS One; 2015; 10(6):e0128618. PubMed ID: 26087209
[TBL] [Abstract][Full Text] [Related]
5. Engineering HIV-1-resistant T-cells from short-hairpin RNA-expressing hematopoietic stem/progenitor cells in humanized BLT mice.
Ringpis GE; Shimizu S; Arokium H; Camba-Colón J; Carroll MV; Cortado R; Xie Y; Kim PY; Sahakyan A; Lowe EL; Narukawa M; Kandarian FN; Burke BP; Symonds GP; An DS; Chen IS; Kamata M
PLoS One; 2012; 7(12):e53492. PubMed ID: 23300932
[TBL] [Abstract][Full Text] [Related]
6. Analysis and dissociation of anti-HIV effects of shRNA to CCR5 and the fusion inhibitor C46.
Ledger S; Howe A; Turville S; Aggarwal A; Savkovic B; Ong A; Wolstein O; Boyd M; Millington M; Gorry PR; Murray JM; Symonds G
J Gene Med; 2018 Feb; 20(2-3):e3006. PubMed ID: 29552747
[TBL] [Abstract][Full Text] [Related]
7. Influence of the loop size and nucleotide composition on AgoshRNA biogenesis and activity.
Herrera-Carrillo E; Harwig A; Berkhout B
RNA Biol; 2017 Nov; 14(11):1559-1569. PubMed ID: 28569591
[TBL] [Abstract][Full Text] [Related]
8. Analysis of AgoshRNA maturation and loading into Ago2.
Harwig A; Kruize Z; Yang Z; Restle T; Berkhout B
PLoS One; 2017; 12(8):e0183269. PubMed ID: 28809941
[TBL] [Abstract][Full Text] [Related]
9. Cell-specific RNA aptamer against human CCR5 specifically targets HIV-1 susceptible cells and inhibits HIV-1 infectivity.
Zhou J; Satheesan S; Li H; Weinberg MS; Morris KV; Burnett JC; Rossi JJ
Chem Biol; 2015 Mar; 22(3):379-90. PubMed ID: 25754473
[TBL] [Abstract][Full Text] [Related]
10. Mechanistic insights on the Dicer-independent AGO2-mediated processing of AgoshRNAs.
Liu YP; Karg M; Harwig A; Herrera-Carrillo E; Jongejan A; van Kampen A; Berkhout B
RNA Biol; 2015; 12(1):92-100. PubMed ID: 25826416
[TBL] [Abstract][Full Text] [Related]
11. A highly efficient short hairpin RNA potently down-regulates CCR5 expression in systemic lymphoid organs in the hu-BLT mouse model.
Shimizu S; Hong P; Arumugam B; Pokomo L; Boyer J; Koizumi N; Kittipongdaja P; Chen A; Bristol G; Galic Z; Zack JA; Yang O; Chen IS; Lee B; An DS
Blood; 2010 Feb; 115(8):1534-44. PubMed ID: 20018916
[TBL] [Abstract][Full Text] [Related]
12. CCR5 Δ32 homozygous cord blood allogeneic transplantation in a patient with HIV: a case report.
Duarte RF; Salgado M; Sánchez-Ortega I; Arnan M; Canals C; Domingo-Domenech E; Fernández-de-Sevilla A; González-Barca E; Morón-López S; Nogues N; Patiño B; Puertas MC; Clotet B; Petz LD; Querol S; Martinez-Picado J
Lancet HIV; 2015 Jun; 2(6):e236-42. PubMed ID: 26423196
[TBL] [Abstract][Full Text] [Related]
13. CXCR4 and CCR5 regulation and expression patterns on T- and monocyte-macrophage cell lineages: implications for susceptibility to infection by HIV-1.
Joly M; Pinto JM
Math Biosci; 2005 May; 195(1):92-126. PubMed ID: 15893340
[TBL] [Abstract][Full Text] [Related]
14. Specific properties of shRNA-mediated CCR5 downregulation that enhance the inhibition of HIV-1 infection in combination with shRNA targeting HIV-1 rev.
Cardona ME; Hinkula J; Gustafsson K; Christensson B; Wahren B; Mohamed AJ; Smith CIE; Arteaga HJ
Mol Biol Rep; 2022 Nov; 49(11):11187-11192. PubMed ID: 36098885
[TBL] [Abstract][Full Text] [Related]
15. Toward optimization of AgoshRNA molecules that use a non-canonical RNAi pathway: variations in the top and bottom base pairs.
Herrera-Carrillo E; Harwig A; Berkhout B
RNA Biol; 2015; 12(4):447-56. PubMed ID: 25747107
[TBL] [Abstract][Full Text] [Related]
16. Restriction of HIV type 1 infection in macrophages heterozygous for a deletion in the CC-chemokine receptor 5 gene.
Ometto L; Zanchetta M; Cabrelle A; Esposito G; Mainardi M; Chieco-Bianchi L; De Rossi A
AIDS Res Hum Retroviruses; 1999 Nov; 15(16):1441-52. PubMed ID: 10555107
[TBL] [Abstract][Full Text] [Related]
17. Protection from HIV-1 infection of primary CD4 T cells by CCR5 silencing is effective for the full spectrum of CCR5 expression.
Butticaz C; Ciuffi A; Muñoz M; Thomas J; Bridge A; Pebernard S; Iggo R; Meylan P; Telenti A
Antivir Ther; 2003 Oct; 8(5):373-7. PubMed ID: 14640383
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous Knockout of CXCR4 and CCR5 Genes in CD4+ T Cells via CRISPR/Cas9 Confers Resistance to Both X4- and R5-Tropic Human Immunodeficiency Virus Type 1 Infection.
Yu S; Yao Y; Xiao H; Li J; Liu Q; Yang Y; Adah D; Lu J; Zhao S; Qin L; Chen X
Hum Gene Ther; 2018 Jan; 29(1):51-67. PubMed ID: 28599597
[TBL] [Abstract][Full Text] [Related]
19. Agonist-induced internalization of CC chemokine receptor 5 as a mechanism to inhibit HIV replication.
Ferain T; Hoveyda H; Ooms F; Schols D; Bernard J; Fraser G
J Pharmacol Exp Ther; 2011 Jun; 337(3):655-62. PubMed ID: 21389095
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of HIV-1 infection by a unique short hairpin RNA to chemokine receptor 5 delivered into macrophages through hematopoietic progenitor cell transduction.
Liang M; Kamata M; Chen KN; Pariente N; An DS; Chen IS
J Gene Med; 2010 Mar; 12(3):255-65. PubMed ID: 20186995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]